Stress-induced hyperthermia and anxiety: Pharmacological validation

European Journal of Pharmacology

Volumn 463, Issue 1-3, 2003, Pages 117-132

  Olivier, Berend ^a,b   Zethof, Theo ^c   Pattij, Tommy ^a   Van Boogaert, Meg ^a   Van Oorschot, Ruud ^a,c   Leahy, Christina ^e   Oosting, Ronald ^a   Bouwknecht, Arjan ^a,d   Veening, Jan ^e   Van Der Gugten, Jan ^a   Groenink, Lucianne ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Solvay Pharmaceuticals Inc   (Netherlands)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e NONE

Author keywords

Anxiety; Body temperature; Mutant mouse; Stress; Stress induced hyperthermia

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; ALCOHOL; ALPIDEM; ALPRAZOLAM; ANPIRTOLINE; BACLOFEN; BENZODIAZEPINE; BRETAZENIL; BUSPIRONE; CHLORDIAZEPOXIDE; DIAZEPAM; DIZOCILPINE; DU 125530; FLESINOXAN; FLUMAZENIL; IPSAPIRONE; KETANSERIN; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXAZEPAM; PENTETRAZOLE; PHENOBARBITAL; RITANSERIN; S UH 301; SEROTONIN 1A AGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; WAY 100 639; ZOLPIDEM;

ANXIETY; BASAL BODY TEMPERATURE; CORE TEMPERATURE; DRUG EFFECT; HYPERTHERMIA; KNOCKOUT MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECTUM TEMPERATURE; REVIEW; SEX DIFFERENCE; SPECIES DIFFERENTIATION; STRESS; TRANQUILIZING ACTIVITY;

EID: 0037470252     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01326-8     Document Type: Review

References (83)

1. Axelrod J., Reisine T.D. Stress hormones: their interaction and regulation. Science. 224:1984;452-459.
2. Bagdy G., Calogro A.E., Murphy D.L., Szemeredi K. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology. 125:1989;2664-2669.
3. Bermant R.I., Levinson D.M., Justesen D.R. Classical conditioning of microwave-induced hyperthermia in rats. Radio Sci. 14:1979;201-207.
4. Bill D.J., Knight M., Forster E.A., Fletcher A. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT induced hypothermia. Br. J. Pharmacol. 10:1991;1857-1864.
5. Borsini F., Lecci A., Volterra G., Meli A. A model to measure anticipatory anxiety in mice? Psychopharmacology. 98:1989;207-211.
6. Bouwknecht J.A., Paylor R. Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains. Behav. Brain Res. 136:2002;489-501.
7. Bouwknecht J.A., Hijzen T.H., van der Gugten J., Maes R.A.A., Olivier B. Stress-induced hyperthermia in mice: effects of flesinoxan on heart rate and body temperature. Eur. J. Pharmacol. 400:2000;59-66.
8. 1B knockout mice. Biol. Psychiatry. 49:2001;557-568.
9. 1A receptor activation. Psychopharmacology. 153:2001;484-490.
10. 1A receptor activation are normal. Psychopharmacology. 153:2001;484-490.
11. 1A receptor function as measured telemetrically on body temperature and heart rate responses. Brain Res. Bull. 57:2002;93-102.
12. Briese E. Emotional hyperthermia and performance in humans. Physiol. Behav. 58:1995;615-618.
13. Briese E., Cabanac M. Stress hyperthermia: physiological arguments that it is a fever. Physiol. Behav. 49:1991;1153-1157.
14. Briese E., DeQuijada M.G. Colonic temperature of rats during handling. Acta Physiol. Latinoam. 20:1970;97-102.
15. Charney D.S., Woods S.W., Goodman W.K., Heninger G.R. Serotonin functions in anxiety: II. Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacology. 92:1987;14-24.
16. 3 receptor antagonist in the elevated X-maze. Psychopharmacology. 3:1989;. (10 pp.).
17. 3 agonist and antagonists for alteration of aversive behaviour in the mouse. Br. J. Pharmacol. 96:1989;325-332.
18. De Boer S.F., Slangen J.L., van der Gugten J. Effects of buspirone and chlordiazepoxide on plasma catecholamines and corticosterone levels in stressed and nonstressed rats. Pharmacol. Biochem. Behav. 38:1991;299-308.
19. De Boer S.F., Slangen J.L., van der Gugten J. Brain benzodiazepine receptor control of stress hormones. Kvetnansky R., McCarty R., Axelrod J. Stress: Neuroendocrine and Modular Approaches. 1992;719-734 Gordon & Breach, New York.
20. Depoortere H., Zivkovic B., Lloyd K.G., Sanger D.J., Perrault G., Langer S.Z., Bartholini G. Zolpidem, a novel nonbenzodiazepine hypnotic: I. Neuropharmacological and behavioral effects. J. Pharmacol. Exp. Ther. 237:1986;649-658.
21. Dirks A., Groenink L., lutje Schipholt M., van der Gugten J., Hijzen T.H., Geyer M.A., Olivier B. Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biol. Psychiatry. 51:2000;583-590.
22. 1A receptor knockout mice, show reduced behavioral reactivity and sensitization by footshocks, as measured with the acoustic startle. Behav. Brain Res. 118:2001;171-180.
23. Dirks A., Groenink L., Verdouw P.M., lutje Schipholt M., van der Gugten J., Hijzen T.H., Olivier B. Behavioral analysis of transgenic mice overexpressing corticotropin-releasing hormone in paradigms emulating aspects of stress, anxiety, and depression. Int. J. Comp. Psychol. 14:2001;123-135.
24. Dirks A., Groenink L., Bouwknecht J.A., Hijzen T.H., van der Gugten J., Ronken E., Verbeek J.S., Veening J.G., Dederen P.J.W.C., Korosi A., Schoolderman L.F., Roubos E.W., Olivier B. Overexpression of corticotropin-releasing hormone in transgenic mice and chronic-stress like autonomic and physiological alterations. Eur. J. Neurosci. 16:2002;1751-1760.
25. Dunn R.W., Kramarcy N.R. Neurochemical responses in stress: relationship between the hypothalamic-pituitary-adrenal and catecholamine systems. Iversen L.L., Iversen S.D., Snyder S.H. Handbook of Psychopharmacology. Drugs, Neurotransmitters and Behavior. vol. 18:1984;455-515 Plenum, New York.
26. 1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur. J. Pharmacol. 169:1989;1-10.
27. Eisenberg R.M. Sound vibration, a non-invasive stress: antagonism by diazepam. Psychopharmacology. 110:1993;467-470.
28. 1A receptor subtype increases rat plasma ACTH concentration. Eur. J. Pharmacol. 147:1988;431-439.
29. Gordon C.J., Becker P., Alis J.S. Behavioral thermoregulatory responses of single- and group-housed mice. Physiol. Behav. 65:1998;255-262.
30. Groenink L., van der Gugten J., Zethof T., Van der Heyden J., Olivier B. Stress-induced hyperthermia in mice: hormonal correlates. Physiol. Behav. 56:1994;747-749.
31. 1A receptor agonist, are not related to its neuroendocrine effects. Eur. J. Pharmacol. 280:1995;185-193.
32. Groenink L., van der Gugten J., Zethof T.J.J., Van der Heyden J.A.M., Olivier B. Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice. Pharmacol. Biochem. Behav. 54:1996;249-253.
33. Groenink L., Dirks A., Verdouw P.M., lutje Schipholt M., Veening J.G., van der Gugten J., Olivier B. HPA-axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol. Psychiatry. 51:2002;875-881.
34. 1A receptor mutant mice. Proc. Natl. Acad. Sci. 95:1998;15049-15054.
35. Henry J.P. Biological basis of the stress response. Integr. Physiol. Behav. Sci. 27:1992;66-83.
36. 1C receptor antagonists. Eur. J. Pharmacol. 164:1989;445-454.
37. Kleitman N. The effect of motion pictures on body temperature. Science. 101:1945;507-508.
38. Korte S.M., Bouws G.A.H., Koolhaas J.M., Bohus B. Neuroendocrine and behavioral responses during conditioned active and passive behavior in the defensive burying/probe avoidance paradigm: effects of ipsapirone. Physiol. Behav. 52:1992;355-361.
39. Langtry H.D., Benfield P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs. 40:1990;291-313.
40. Lecci A., Borsini F., Volterra G., Meli A. Pharmacological validation of a novel animal model of anticipatory anxiety in mice. Psychopharmacology. 101:1990;255-261.
41. Lecci A., Borsini F., Mancinelli A., D'Aranno V., Stasi A., Volterra G., Meli A. Effect of serotonergic drugs on stress-induced hyperthermia (SIH) in mice. J. Neural Transm. 82:1990;219-230.
42. Lecci A., Borsini F., Gragnani L., Volterra G., Meli A. Effect of psychotomimetics and some putative anxiolytics on stress-induced hyperthermia. J. Neural Transm. 83:1991;67-76.
43. Marazziti D., Di Muro A., Castrogiovanni P. Psychological stress and body temperature changes in humans. Physiol. Behav. 52:1992;393-395.
44. Matheson G.K., Gage D., White G., Dixon V., Gipson D. A comparison of the effects of buspirone and diazepam on plasma corticosterone levels in the rat. Neuropharmacology. 27:1988;823-830.
45. 1A receptor agonists in mice. Eur. J. Pharmacol. 18:1990;295-297.
46. Najim R.A., Al-Essu L.Y., Al-Jibouri L.M. Benzodiazepine-induced hyperglycemia. Med. Sci. Res. 15:1987;95-96.
47. 1A receptor-mediated temperature and corticosterone responses in mice. Eur. J. Pharmacol. 219:1992;339-341.
48. Oka T., Oka K., Hori T. Mechanisms and mediators of psychological stress-induced rise in core temperature. Psychosom. Med. 63:2001;476-486.
49. Olivier B., Mos J., van der Heyden J.A.M., Tulp M. Th. M., Slangen J.L. Anxiolytic properties of 5-HT3 antagonists: A review. Stress Medicine. 8:1992;117-136.
50. Olivier B., Mos J., van der Heyden J.A.M., Molewijk H.E., van Dijken H.H., Zethof T., van Hest A., Tulp M. Th. M., Slangen J.L. Functional correlates of 5-HT receptors, clinical applications and possibilities of serotonergic drugs. Claassen V. Trends in receptor research. vol. 20:1993;97-122 Elsevier, Amsterdam.
51. 1A receptor mediated. Eur. J. Pharmacol. 342:1998;177-182.
52. Olivier B., van Wijngaarden I., Soudijn W. 5-HT3 receptor antagonists and anxiety: a preclinical and clinical review. Eur. Neuropsychopharmacol. 10:2000;77-95.
53. 1A receptor knockout mouse and anxiety. Behav. Pharmacol. 12:2001;439-450.
54. A-benzodiazepine receptor complex ligands and stress-induced hyperthermia in singly housed mice. Pharmacol. Biochem. Behav. 72:2002;179-188.
55. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin 1A receptor. Proc. Natl. Acad. Sci. 95:1998;10734-10739.
56. 1A receptor knockout mice on a 129/Sv background. Eur. J. Pharmacol. 447:2002;67-74.
57. 1A receptor knockout mice. Neuropsychopharmacology. 27:2002;380-390.
58. 1A receptor knockout mouse is normal. Biol. Psychiatry. 49:2001;569-574.
59. Peloso E., Wachulec M., Satnoff E. Stress-induced hyperthermia depends on both time of day and light condition. J. Biol. Rhythms. 17:2002;164-170.
60. Pericic D., Lakic N., Manev H. Effect of diazepam on plasma corticosterone. Psychopharmacology. 83:1984;79-81.
61. Ramboz S., Oosting R., Ait Amara D., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety related disorder. Proc. Natl. Acad. Sci. 95:1998;14476-14481.
62. Reeves D.L., Levinson D.M., Justesen D.R., Lubin B. Endogenous hyperthermia in normal human subjects: experimental study of emotional states (II). Int. J. Psychosom. 32:1985;18-23.
63. Renbourn E.T. Body temperature and pulse rate in boys and young men prior to sporting contests. A study of emotional hyperthermia: with a review of the literature. J. Psychosom. Res. 4:1960;149-175.
64. Rothwell N.J. Central effects of CRF on metabolism and energy balance. Neurosci. Biobehav. Rev. 14:1990;263-271.
65. Salmi P., Karlsson T., Ahlenius S. Antagonism by Sch 23390 of clozapine-induced hypothermia in the rat. Eur. J. Pharmacol. 253:1994;67-73.
66. B receptor antagonist. Br. J. Pharmacol. 104:1991;239-245.
67. Smythe G.A., Pascoe W.S., Storlien L.H. Hypothalamic noradrenergic and sympathoadrenal control of glycemia after stress. Am. J. Physiol. 256:1989;E231-E235.
68. Spooren W.P.J.M., Vassout A., Neijt H.C., Kuhn R., Gasparini F., Roux S., Porsolt R.D., Gentsch C. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J. Pharmacol. Exp. Ther. 295:2000;1267-1275.
69. Spooren W.P.J.M., Schoeffter P., Gasparini F., Kuhn R., Gentsch C. Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur. J. Pharmacol. 435:2002;161-170.
70. Steffens A.B., Damsma G., van der Gugten J., Luiten P.G.M. Circulating free fatty acids, insulin, and glucose during chemical stimulation of hypothalamus in rats. Am. J. Physiol. 247:1984;E765-E771.
71. Urban J.H., Van de Kar L.D., Lorens S.A., Bethea C.L. Effect of the anxiolytic buspirone on prolactin and corticosterone secretion in stressed and unstressed rat. Pharmacol. Biochem. Behav. 25:1986;457-462.
72. Van der Heyden J.A.M., Zethof T.J.J., Olivier B. Stress-induced hyperthermia in singly housed mice. Physiol. Behav. 62:1997;63-70.
73. Watanabe T., Hashimoto M., Okuyama S., Inagami T., Nakamura S. Effects of targeted disruption of the mouse angiotensin II type 2 receptor gene on stress-induced hyperthermia. J. Physiol. 515:1999;881-885.
74. Willner P. Behavioural models in psychopharmacology. Willner P. Behavioural Models in Psychopharmacology. 1991;3-18 Cambridge Univ. Press, Cambridge.
75. Yazumi T., Ogata J., Ishida M. Analysis of body temperature at different sites in patients having slight fever caused by psychogenic stress. Lomax P., Schonbaum S. Thermoregulation: Research and Clinical Applications. 1989;169-172 Karger, Basel.
76. Yokoi Y. Effect of ambient temperature upon emotional hyperthermia and hypothermia in rabbits. J. Appl. Physiol. 21:1966;1795-1798.
77. Yoshiue S., Yoshizawa H., Ito H., Sekine H., Nakamura M., Kanamori T., Suzuki H., Yazumi T., Ogata J., Ishida M. Analysis of body temperature at different sites in patients having slight fever caused by psychogenic stress. Lomax P., Schonbaum S. Thermoregulation: Research and Clinical Applications. 1989;169-172 Karger, Basel.
78. Zethof T.J.J., Van der Heyden J.A.M., Olivier B. A new animal model for anticipatory anxiety? Olivier B., Mos J., Slangen J. Animal Models in Psychopharmacology. 1991;65-68 Birkhäuser-Verlag, Basel.
79. Zethof T.J.J., Van der Heyden J.A.M., Tolboom J.T.B.M., Olivier B. Stress-induced hyperthermia in mice: a methodological study. Physiol. Behav. 55:1994;109-115.
80. Zethof T.J.J., Van der Heyden J.A.M., Tolboom J.T.B.M., Olivier B. Stress-induced hyperthermia as a putative anxiety model. Eur. J. Pharmacol. 294:1995;125-135.
81. Zivkovic N., Morel E., Joly D., Perrault G., Sanger D.J., Lloyd K.G. Pharmacological and behavioural profile of alpidem as an anxiolytic. Psychopharmacology. 23(Suppl. 3):1990;108-113.
82. Zuideveld K.P., Maas H.J., Treijtel N., Hulshof J., van der Graaf P.H., Peletier L.A., Danhof M. A set-point model with oscillatory behavior predicts the time-course of 8-OH-DPAT-induced hypothermia. Am. J. Physiol. 281:2001;R2059-R2071.
83. Zuideveld K.P., Treytel N., Maas H.J., Gubbens-Stibbe J.M., Peletier L.A., van der Graaf P.H., Danhof M. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-8-OH-DPAT-induced hypothermia. J. Pharmacol. Exp. Ther. 300:2002;330-338.